Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
TelehealthReviewed.com Announces Editorial Series on Provider-Guided Weight Management Platforms
Via AB Newswire
Exposures Product Safety
News headline image
Praxis' Seizure Drug Move Towards Faster Development After Positive Trial Results ↗
Via Benzinga
Exposures Product Safety
News headline image
FDA Declines To Approve Achieve Life Sciences' Smoking Cessation Drug; Q4 Resubmission Planned ↗
Via Benzinga
Exposures Product Safety
News headline image
NovoCure vs. Omeros: Which Emerging Pharmaceutical Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
Tickers NVCR OMER
Exposures Product Safety
News headline image
STT Security Services Examines the Role of Food Production Security in Protecting Product Integrity and Operational Continuity
Via Press Advantage
Topics Product Recall
Exposures Legal Product Safety
News headline image
Regenxbio Gains Fresh Chance As FDA Reconsiders Gene Therapy ↗
Via Benzinga
Exposures Product Safety
News headline image
WSTPR Catalyst Watch: Abu Dhabi Regulatory Clearance Adds Momentum to NeOnc's Global Neuro-Oncology Strategy
Via Newsfile
Tickers LLY NTHI
Exposures Product Safety
News headline image
Why Is MoonLake Immunotherapeutics Stock Soaring Monday? ↗
Via Benzinga
Exposures Product Safety
News headline image
A Blood Test That Screens for 50+ Cancers Just Moved Closer to Real-World Use. Here's What It Means for Grail Investors. ↗
Via The Motley Fool
Tickers GRAL GS
Exposures Product Safety
News headline image
Lose the Fat. Keep the Muscle and the Face.
Via Press Release Distribution Service
Exposures Product Safety
News headline image
Elon Musk's Mom Recalls Buying His Only $99 Suit As Billionaire-Turned-Trillionaire's Early Struggles Resurface: 'He Was Fine With That' ↗
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
News headline image
3 Biotech Firms With Major Potential Catalysts in the Coming Months ↗
Via MarketBeat
Topics Intellectual Property
Tickers ADMA KRYS VERA
Exposures Intellectual Property Product Safety
News headline image
Modern Overview of Psychedelic, Dissociative, and Cannabinoid Compounds ↗
Via Talk Markets
Exposures Product Safety
News headline image
Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
Tickers NTLA OMER
Exposures Product Safety
News headline image
Moderna Has Some Key Approvals Ahead. Is the Stock a Buy? ↗
Via The Motley Fool
Tickers MRNA
Exposures COVID-19 Product Safety
News headline image
Investors of Medline Inc. (NASDAQ: MDLN) are Encouraged to Contact Kaplan Fox Regarding the Investigation of Potential Securities Law Violations
Via TheNewswire.com
Tickers MDLN
Exposures Product Safety
News headline image
Investors of Medline Inc. (NASDAQ: MDLN) are Encouraged to Contact Kaplan Fox Regarding the Investigation of Potential Securities Law Violations
Via NewMediaWire
Tickers MDLN
Exposures Product Safety
News headline image
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Faces Possible Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
Via TheNewswire.com
Tickers FULC
Exposures Product Safety
News headline image
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Faces Possible Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Tickers FULC
Exposures Product Safety
News headline image
Psychiatric Hospitals Fail to Warn Electroshock Patients of FDA-Cited Risks in Estimated $7 Billion Industry
Via PRLog
Exposures Product Safety
News headline image
Kaplan Fox is Investigating Potential Securities Law Violations Against Medline Inc. (NASDAQ: MDLN)
Via NewMediaWire
Tickers MDLN
Exposures Product Safety
News headline image
Kaplan Fox is Investigating Potential Securities Law Violations Against Medline Inc. (NASDAQ: MDLN)
Via TheNewswire.com
Tickers MDLN
Exposures Product Safety
News headline image
Missed Out on the AI Memory Rally? These 3 Stocks Are Just Getting Started. ↗
Via The Motley Fool
Topics Artificial Intelligence Product Recall
Tickers LRCX RMBS TER
Exposures Artificial Intelligence Legal Product Safety
News headline image
Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) to Contact the Firm
Via TheNewswire.com
Tickers FULC
Exposures Product Safety
News headline image
Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) to Contact the Firm
Via NewMediaWire
Tickers FULC
Exposures Product Safety
News headline image
Teva Just Delivered More Good News on Its Biggest Growth Driver. Is the Stock Still a Bargain? ↗
Via The Motley Fool
Tickers NVS RHHBY TEVA
Exposures Product Safety
News headline image
QURE Was Just the Beginning: 5 Biotech Catalysts I’m Watching Now ↗
Via InvestorPlace
Tickers CELC CLDX IONS QURE REPL TVTX
Exposures Product Safety
News headline image
Moderna's Flu Vaccine Clears Key FDA Panel Vote As Advisory Committee Backs Shot 9-0 ↗
Via Benzinga
Exposures Product Safety
News headline image
What You Should Know Before Buying Ivermectin Capsules Online ↗
Via Talk Markets
Exposures Product Safety
News headline image
Psychiatric Hospitals Fail to Warn Electroshock Patients of FDA-Cited Risks in Estimated $7 Billion Industry
Via 24-7 Press Release
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.